Pyxis Oncology Inc (PYXS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -27.99 | -85.64 | -52.365 | -49.132 | -38.322 |
Return on Equity (%) | 192.902 | 138.539 | -61.852 | -57.193 | -51.506 |
Return on Invested Capital (%) | -30.245 | -102.228 | -52.146 | -58.518 | -55.863 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 3.62 | 0.768 | 8.11 | 4.6 | 1.744 |
Earnings Per Share | -0.526 | -1.565 | -2.358 | -3.453 | -1.269 |
Cash Per Share | 3.738 | 0.985 | 8.526 | 5.129 | 0.166 |
Working Capital Per Share | 3.601 | 0.538 | 8.068 | 4.433 | 1.7 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.526 | -1.565 | -2.351 | -3.453 | -1.269 |
EBITDA Per Share | -0.526 | -1.565 | -2.351 | -3.453 | -1.269 |
Free Cash Flow Per Share | -0.526 | -1.441 | -2.36 | -3.29 | -1.187 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 5,27M | 8,2M | 32,22M | 34,96M | 58,13M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 34,96M | N/A | N/A | N/A | 58,13M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -20.166 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -20.166 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 95,74M |
Ratio cours/bénéfice | -1,24 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 9,48 |
Ratio prix/valeur comptable | 0,73 |
Rendement de dividende | - |
Actions en circulation | 59,47M |
Volume moyen (1 semaine) | 595,15k |
Volume moyen (1 mois) | 835,01k |
Variation sur 52 semaines | -28,63% |
Plus haut sur 52 semaines | 6,85 |
Plus bas sur 52 semaines | 1,49 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales